期刊文献+
共找到1,596篇文章
< 1 2 80 >
每页显示 20 50 100
Reduced mesencephalic astrocyte-derived neurotrophic factor expression by mutant androgen receptor contributes to neurodegeneration in a model of spinal and bulbar muscular atrophy pathology
1
作者 Yiyang Qin Wenzhen Zhu +6 位作者 Tingting Guo Yiran Zhang Tingting Xing Peng Yin Shihua Li Xiao-Jiang Li Su Yang 《Neural Regeneration Research》 SCIE CAS 2025年第9期2655-2666,共12页
Spinal and bulbar muscular atrophy is a neurodegenerative disease caused by extended CAG trinucleotide repeats in the androgen receptor gene,which encodes a ligand-dependent transcription facto r.The mutant androgen r... Spinal and bulbar muscular atrophy is a neurodegenerative disease caused by extended CAG trinucleotide repeats in the androgen receptor gene,which encodes a ligand-dependent transcription facto r.The mutant androgen receptor protein,characterized by polyglutamine expansion,is prone to misfolding and forms aggregates in both the nucleus and cytoplasm in the brain in spinal and bulbar muscular atrophy patients.These aggregates alter protein-protein interactions and compromise transcriptional activity.In this study,we reported that in both cultured N2a cells and mouse brain,mutant androgen receptor with polyglutamine expansion causes reduced expression of mesencephalic astrocyte-de rived neurotrophic factor.Overexpressio n of mesencephalic astrocyte-derived neurotrophic factor amelio rated the neurotoxicity of mutant androgen receptor through the inhibition of mutant androgen receptor aggregation.Conversely.knocking down endogenous mesencephalic astrocyte-derived neurotrophic factor in the mouse brain exacerbated neuronal damage and mutant androgen receptor aggregation.Our findings suggest that inhibition of mesencephalic astrocyte-derived neurotrophic factor expression by mutant androgen receptor is a potential mechanism underlying neurodegeneration in spinal and bulbar muscular atrophy. 展开更多
关键词 androgen receptor mesencephalic astrocyte-derived neurotrophic factor mouse model NEURODEGENERATION neuronal loss neurotrophic factor polyglutamine disease protein misfolding spinal and bulbar muscular atrophy transcription factor
下载PDF
三阴性乳腺癌组织中EGR1、AR、H3K4me3表达与其临床病理特征及预后的相关性
2
作者 王丽 杜闯 +2 位作者 张亚青 李聪 王静 《实用癌症杂志》 2024年第10期1604-1607,共4页
目的探讨三阴性乳腺癌组织中早期生长反应基因1(EGR1)、雄激素受体(AR)、组蛋白H3第4位赖氨酸三甲基化(H3K4me3)表达与其临床病理特征及预后的相关性。方法回顾性分析89例三阴性乳腺癌患者的临床资料,所有患者均行手术治疗,采用免疫组... 目的探讨三阴性乳腺癌组织中早期生长反应基因1(EGR1)、雄激素受体(AR)、组蛋白H3第4位赖氨酸三甲基化(H3K4me3)表达与其临床病理特征及预后的相关性。方法回顾性分析89例三阴性乳腺癌患者的临床资料,所有患者均行手术治疗,采用免疫组化染色法测定EGR1、AR、H3K4me3表达,比较肿瘤组织及癌旁正常组织内EGR1、AR、H3K4me3表达差异,分析EGR1、AR、H3K4me3表达与其临床病理的关系,分析EGR1、AR、H3K4me3表达与其预后的关系。结果肿瘤组织内EGR1阳性表达率、AR阳性表达率低于对照组,H3K4me3阳性表达率高于对照组,差异有统计学意义(P<0.05);EGR1阳性表达、AR阳性表达患者临床分期Ⅰ~Ⅱ期、无淋巴结转移、中高分化占比高于EGR1阴性表达、AR阴性表达患者,H3K4me3阳性表达患者临床分期Ⅲ期、淋巴结转移、低分化占比高于H3K4me3阴性表达患者,差异有统计学意义(P<0.05);随访1年,89例患者共36例出现复发转移,发生率为40.45%(36/89);复发转移组EGR1阳性表达、AR阳性表达率低于未复发转移组,H3K4me3阳性表达率高于未复发转移组,差异有统计学意义(P<0.05)。结论EGR1、AR在三阴性乳腺癌中多呈阴性表达,H3K4me3则以阳性表达为主,三者表达均与临床分期、淋巴结转移及分化程度存在密切关系,或可作为临床治疗的新靶点。 展开更多
关键词 三阴性乳腺癌 早期生长反应基因1 雄激素受体 临床病理特征 预后
下载PDF
AR、SKP2、SOX10、PD-L1及TIL表达在三阴性乳腺癌中的意义
3
作者 刘娟 殷丽娟 范德生 《诊断学理论与实践》 2024年第2期162-172,共11页
目的:探索雄激素受体(androgen receptor,AR)、S期激酶相关蛋白2(S-phase kinase-associated protein 2,SKP2)、性别决定区Y相关的HMG盒含因子10(sry-related HMG box-containing factor 10,SOX10)、程序性死亡配体1(programmed death-l... 目的:探索雄激素受体(androgen receptor,AR)、S期激酶相关蛋白2(S-phase kinase-associated protein 2,SKP2)、性别决定区Y相关的HMG盒含因子10(sry-related HMG box-containing factor 10,SOX10)、程序性死亡配体1(programmed death-ligand 1,PD-L1)及肿瘤浸润性淋巴细胞(tumor infiltrating lymphocyte,TIL)在三阴性乳腺癌(triple negative breast cancer,TNBC)表达与临床病理特征和预后的关系。方法:根据苏木精-伊红染色(hematoxylineosin, HE)染色切片评判109例TNBC瘤巢内TIL的比例,采用Leica Bond-Max全自动免疫组化仪检测TNBC组织中AR、SKP2、SOX10、PD-L1的表达。分析以上各生物指标与临床病理特征间的关系,并采用kaplan-Meier、Log-rank进行生存分析。结果:95例患者获得随访,中位随访时间为48个月,中位无病生存时间(disease-free survival, DFS)为42个月,中位总生存时间(overall survival, OS)48个月。在TNBC中,AR阳性表达与淋巴结转移阴性(P=0.009)、肿瘤最大径<2 cm(P=0.008)相关,TIL高表达与低级别TNBC相关(P=0.007),SKP2阳性表达与神经/脉管侵犯阳性(P=0.011)、高级别TNBC相关(P=0.002),SOX10阳性表达与淋巴结转移阳性(P=0.022)、高级别TNBC(P=0.005)相关,PD-L1阳性表达与淋巴结转移阳性(P=0.020)、神经/脉管侵犯阳性(P=0.006)、高级别TNBC(P=0.042)相关。生存分析显示,SKP2、SOX10阳性表达与更差的DFS(P=0.007、P<0.001)和OS(P=0.013、P<0.001)相关,TIL高表达与更好的DFS(P=0.016)及OS(P=0.004)相关。在生物表志物的联合表达中,AR+/SKP2-、AR+/SOX10-与更好的DFS(P=0.004、P<0.001)及OS(P=0.007、P=0.001)相关,SOX10+/低TIL、PD-L1+/低TIL与更差的DFS(P<0.001、P=0.008)及OS(P=0.001、P=0.002)相关,AR-/低TIL者具有更差的OS(P=0.014)。SKP2(HR=4.143,95%CI为1.578~10.875)、SOX10(HR=7.578,95%CI为2.067~27.782)的阳性表达是影响TNBC患者DFS的独立预后因子,SKP2(HR=3.758,95%CI为1.400~10.084)、SOX10(HR=5.131,95%CI为1.316~20.000)及TIL(HR=0.375,95%CI为0.154~0.917)的阳性表达是TNBC患者OS的独立预后因子(P均<0.05)。结论:在TNBC中,AR阳性、TIL高表达与具有更好预后的临床病理特征相关,SKP2、SOX10和PD-L1与具侵袭性的临床病理特征相关。SKP2、SOX10及TIL表达与TNBC预后相关,提示这些生物指标可能成为TNBC新的预后因子,同时它们也有可能成为潜在的治疗靶点。 展开更多
关键词 三阴性乳腺癌 雄激素受体 S期激酶相关蛋白2 性别决定区Y相关的HMG盒含因子10 程序性死亡配体1 肿瘤浸润性淋巴细胞
下载PDF
乳腺癌ER、AR表达与术前MRI征象的相关性分析 被引量:1
4
作者 张士朋 姚立国 +7 位作者 王彦龙 曹静 张旭霞 张志强 苟芳丽 彭梅娟 谢一婧 朱大林 《中国CT和MRI杂志》 2024年第2期85-88,共4页
目的探讨乳腺癌ER、AR表达与术前MRI征象的相关性。方法收集甘肃省妇幼保健院2019年1月至2022年1月乳腺癌患者共计234例,依据术后免疫组化将其分为ER、AR双表达组、共计155例,ER、AR非双表达组、共计79例,采用Sperman及两独立样本t检验... 目的探讨乳腺癌ER、AR表达与术前MRI征象的相关性。方法收集甘肃省妇幼保健院2019年1月至2022年1月乳腺癌患者共计234例,依据术后免疫组化将其分为ER、AR双表达组、共计155例,ER、AR非双表达组、共计79例,采用Sperman及两独立样本t检验对ER、AR双表达与术前MRI征象进行单因素相关性分析,筛选存在统计学意义的MRI征象并进行多因素Logistic相关性分析。结果乳腺癌AR、ER表达与肿瘤形态之间差异无统计学意义(均P>0.05),与瘤体直径、环形强化及瘤周水肿之间差异具有统计学意义(均P<0.05),乳腺癌AR、ER双表达者肿瘤直径更小,环形强化及瘤周水肿更少见,二元Logistic回归分析表明环形强化(OR=0.421,P=0.041),瘤周水肿(OR=0.505,P=0.025)与乳腺癌AR、ER双表达相关。结论术前MRI征象与乳腺癌AR、ER双表达有较好的相关性,乳腺癌AR、ER双表达者瘤周水肿、环形强化少见,肿瘤组织学分级低,侵袭性弱。 展开更多
关键词 乳腺癌 雌激素受体 雄激素受体 磁共振成像
下载PDF
Androgen receptors are expressed in a variety of human fetal extragenital tissues: an immunohistochemical study 被引量:5
5
作者 Yasmin Sajjad Siobhan Quenby +2 位作者 Paul Nickson David Iwan Lewis-Jones Gill Vince 《Asian Journal of Andrology》 SCIE CAS CSCD 2007年第6期751-759,共9页
Aim: To investigate the expression of androgen receptors in the extragenital tissues of developing human embryo. Methods: Using immunohistochemistry, we investigated the distribution of androgen receptor (AR) in t... Aim: To investigate the expression of androgen receptors in the extragenital tissues of developing human embryo. Methods: Using immunohistochemistry, we investigated the distribution of androgen receptor (AR) in the extragenital tissues of paraffin-embedded tissue sections of first trimester (8-12 weeks gestation) human embryos. Gender was determined by polymerized chain reaction. Results: There were no differences in the expression and distribution of AR in male and female embryos at any stage of gestation. AR expression was seen in the thymus gland. The bronchial epithelium of the lungs showed intense positive staining with surrounding stroma negative. Furthermore, positive staining for androgen receptor was exhibited in the spinal cord with a few positive cells in the surrounding tissues. Cardiac valves also showed strong positive staining but with faint reactivity of the surrounding cardiac muscle. There was no staining in kidney, adrenal, liver or bowel. Conclusion: This study demonstrates that immunoreactive AR protein is present in a wide variety of human first trimester fetal tissues and shows the potential for androgen affecting tissues, which are mostly not considered to be androgen dependent. Moreover, it implies that androgen might act as atrophic factor and affect the early development of these organs rather than simply sexual differentiation. 展开更多
关键词 human androgen receptor extragenital tissues tissue distribution fetal tissues IMMUNOHISTOCHEMISTRY
下载PDF
SARMs在肌少症治疗中的机制与进展
6
作者 袁瑾 方玲娜 李翀 《中国骨质疏松杂志》 CAS CSCD 北大核心 2024年第5期775-780,共6页
肌少症(sarcopenia)是当前一类严重影响老年人的日常行为能力和生活质量的疾病。因其发病率逐年增多,近些年各专家对于肌少症的研究也逐步深入。肌少症的治疗方法和治疗药物的研究备受关注,其中,选择性雄激素受体调节剂(selective andro... 肌少症(sarcopenia)是当前一类严重影响老年人的日常行为能力和生活质量的疾病。因其发病率逐年增多,近些年各专家对于肌少症的研究也逐步深入。肌少症的治疗方法和治疗药物的研究备受关注,其中,选择性雄激素受体调节剂(selective androgen receptor modulators,SARMs)是一大研究热点,本篇综述的主要目的是探讨SARMs在肌少症的发生发展中的作用机制、研究和临床进展,以便于未来能更快更好地应用于临床治疗。 展开更多
关键词 肌少症 选择性雄激素受体调节剂 雄激素 雄激素受体
下载PDF
Correlations between Expression of Estrogen and Androgen Receptors and the Clinical Characteristics of Prolactinoma~*
7
作者 约翰 王雄伟 +2 位作者 张华楸 舒凯 雷霆 《The Chinese-German Journal of Clinical Oncology》 CAS 2006年第1期24-27,共4页
Objective: To study the correlations between estrogen receptor (ER) and androgen receptor (AR) and the clinical presentations of prolactinoma and investigate the effect of ER and AR expression on the pathogenesis... Objective: To study the correlations between estrogen receptor (ER) and androgen receptor (AR) and the clinical presentations of prolactinoma and investigate the effect of ER and AR expression on the pathogenesis of prolactinoma in sexual difference. Methods: The clinical data of 30 patients who had undergone transsphenoidal operations in Tongji Hospital from December 2000 to December 2001 were reviewed retrospectively. The clinical information included sex, age, serum-prolactin, size, tumor invasiveness, history of use of bromocriptine and frequency of recurrence. In 20 out of the 30 patients, the ER and AR expression was detected by using immunohistochemistry method. With help of Chi-square test, the relationship between ER, AR and the clinical presentations was analyzed. Results: The statistical values revealed that there was no significant correlation between the ER and AR expression levels with the clinical presentations such as sex, age, tumor size or tumor invasiveness among the 20 patients studied (P〉0.05). Conclusion: The expression of ER or AR is not influenced by the clinical data of prolactinoma such as sex, age, tumor diameter or extent of tumor invasiveness. The tumor is more aggressive in males than in females. In maroadenoma or tumor with hyperprolactineamia (〉200 ng/mL) simple surgical treatment can't successfully cure the prolactinoma. Post-operative bromocriptine therapy can't be determined by the sex of the patients, but is greatly related to the tumor size and serum-prolactin level before operation. 展开更多
关键词 PROLACTINOMA estrogen receptor androgen receptor BROMOCRIPTINE
下载PDF
Mating behavior induces changes of expression of Fos protein,plasma testosterone and androgen receptors in the accessory olfactory bulb (AOB) of the male mandarin vole Microtus mandarinus 被引量:1
8
作者 Fengqin HE Fadao TAI 《Current Zoology》 SCIE CAS CSCD 北大核心 2009年第4期288-295,共8页
In order to investigate the neuroendocrine mechanism of the mating behavior in the adult male mandarin voles Microtus mandarinus,the radioimmunoassay(RIA)and immunohistochemistry methods were used to investigate the d... In order to investigate the neuroendocrine mechanism of the mating behavior in the adult male mandarin voles Microtus mandarinus,the radioimmunoassay(RIA)and immunohistochemistry methods were used to investigate the differences in plasma testosterone(T)concentrations and distribution of T immunoreactive neurons(T-IRs),androgen receptor immunoreactive neurons(AR-IRs)and Fos protein immunoreactive neurons(Fos-IRs)in the accessory olfactory bulb(AOB)and the main olfactory bulb(MOB)following exposure to clean hard-wood shavings(control group),soiled bedding(exposure group)or contact with an estrous female(mating group).Results showed that plasma T concentration was significantly higher in the mating group than that in the exposure group,and both the mating group and the exposure group displayed significantly higher plasma T concentration than the control group.T-IRs,AR-IRs and Fos-IRs were investigated with the immunohistochemistry method in granule cell(GC)and mitral cell(MC)of the MOB and the AOB in the three groups.There were significantly more T-IRs,AR-IRs and Fos-IRs in MC and GC of the AOB in the mating group than that in the exposure group or the control group.T-IRs,AR-IRs and Fos-IRs did not show significant differences between the exposure group and the control group.Furthermore,obvious differences in MC and GC of the MOB were not found among the three groups.The results confirm that both changes of T and AR in the AOB might be underlying mating behavior in the adult male mandarin voles. 展开更多
关键词 Mandarin voles Microtus mandarinus Main olfactory bulb (MOB) Accessory olfactory bulb (AOB) Testosterone(T) androgen receptor ar Fos protein Mating behavior
下载PDF
宫颈腺癌患者细胞质-细胞核AR表达比率的预后意义
9
作者 郭祺 王露露 +2 位作者 颜童 陈睿琳 周怀君 《东南大学学报(医学版)》 CAS 2024年第3期329-336,共8页
目的:利用免疫组化探究雄激素受体(AR)在宫颈腺癌中的表达模式及其与预后的关系。方法:对30例因子宫腺肌症等良性疾病而接受全子宫切除术患者的正常宫颈组织标本,和86例因宫颈腺癌而接受全子宫切除术患者的肿瘤组织标本进行AR免疫组化染... 目的:利用免疫组化探究雄激素受体(AR)在宫颈腺癌中的表达模式及其与预后的关系。方法:对30例因子宫腺肌症等良性疾病而接受全子宫切除术患者的正常宫颈组织标本,和86例因宫颈腺癌而接受全子宫切除术患者的肿瘤组织标本进行AR免疫组化染色,收集研究对象的一般资料,根据AR表达情况评估各临床病理特征与患者临床结局之间的关系。结果:83%(25/30)的正常宫颈组织显示AR在细胞核阳性表达,细胞质不表达,而与正常宫颈组织相比,AR在宫颈腺癌组织则呈现出不同的表达模式,94%(81/86)的患者有AR染色,其中82%(66/81)显示出核-质双染色,12%(10/81)显示出明显的单一胞质阳性,只有6%(5/81)的患者显示出与正常宫颈组织相似的单一核染色。且在核-质双染色的患者中,细胞质表达更为明显。为了更为准确地描述AR在肿瘤细胞不同亚细胞定位的表达情况,我们采用细胞质/细胞核比率对其表达进行量化。比率>2.5组更易发生淋巴结转移(P<0.01)和肌层浸润(P<0.01),且波形蛋白(vimentin)阳性率较高(P<0.01)。Kaplan-Meier分析显示,细胞质与细胞核AR表达比率越高,生存率越低。单变量和多变量Cox回归分析表明,AR胞质/胞核表达比率是远处转移的独立预后因素。结论:AR的细胞质与细胞核表达比率是一个独立的预后因素,有望成为宫颈腺癌患者远处转移风险的预测指标。 展开更多
关键词 雄激素受体 质核比率 宫颈腺癌 免疫组织化学 预后
下载PDF
雄激素受体调控的lncRNA ARLNC1对前列腺癌细胞增殖、克隆、迁移和细胞周期的影响
10
作者 郑江婷 尹冶 +1 位作者 寸淑娥 王玉明 《现代肿瘤医学》 CAS 2024年第2期220-226,共7页
目的:探讨雄激素受体(androgen receptor,AR)调控的长链非编码RNA(long non-coding RNA,lncRNA)ARLNC1对前列腺癌细胞增殖、克隆、迁移和细胞周期的影响。方法:选取正常前列腺上皮细胞株WPMY-1和前列腺癌细胞株PC3、VCaP、22RV1、DU145... 目的:探讨雄激素受体(androgen receptor,AR)调控的长链非编码RNA(long non-coding RNA,lncRNA)ARLNC1对前列腺癌细胞增殖、克隆、迁移和细胞周期的影响。方法:选取正常前列腺上皮细胞株WPMY-1和前列腺癌细胞株PC3、VCaP、22RV1、DU145和LNCaP为研究对象,qRT-PCR分析lncRNA ARLNC1的表达水平;双氢睾酮(DHT)以时间和浓度依赖的方式刺激LNCaP细胞,分析lncRNA ARLNC1的转录水平;采用数据库预测和双荧光素酶报告基因系统分析雄激素受体与lncRNA ARLNC1的关系;将LNCaP细胞分为sh-NC和sh-lncRNA ARLNC1组,采用CCK-8分析细胞增殖,检测细胞克隆和迁移能力;流式细胞仪分析细胞周期变化,Western blot分析细胞周期蛋白CyclinD1、CDK6、p27的表达水平。结果:与正常前列腺上皮细胞相比,lncRNA ARLNC1在雄激素依赖性前列腺癌细胞株(LNCaP、VCaP、22RV1)中的表达水平明显增加,而在雄激素非依赖性前列腺癌细胞株(PC3、DU145)中几乎不表达(P<0.05),其中LNCaP细胞变化最显著,所以下续选用LNCaP细胞作为实验株。100 nmol/L DHT刺激LNCaP细胞0、6、12、18、24 h后,lncRNA ARLNC1的转录水平相对于对照组以时间依赖的方式逐渐升高(P<0.05);不同浓度(0、0.1、1、10、100 nmol/L)DHT刺激LNCaP细胞24 h后,lncRNA ARLNC1转录水平随浓度不断增加(P<0.05);JASPAR数据库预测到lncRNA ARLNC1启动子区域有AR结合的位点,双荧光素酶报告基因系统表明AR能结合在lncRNA ARLNC1启动子区域,并激活其转录(P<0.05);与sh-NC组相比,sh-lncRNA ARLNC1组细胞增殖、迁移和克隆能力减弱,细胞周期阻滞在S、G 2期(P<0.05);sh-NC组相对于sh-lncRNA ARLNC1组,CyclinD1、CDK6蛋白水平增加,而p27蛋白水平降低(P<0.05)。结论:AR调控的lncRNA ARLNC1作为癌基因在雄激素受体阳性的前列腺癌细胞系中高表达,能促进前列腺癌细胞的增殖、克隆、迁移和细胞周期进展。 展开更多
关键词 前列腺癌 长链非编码RNA 雄激素受体 增殖 克隆 迁移 细胞周期
下载PDF
AR及Ki-67表达水平与三阴性乳腺癌超声特征的关系
11
作者 胡艳 邹丽 邓志坚 《中国医学创新》 CAS 2024年第32期139-143,共5页
目的:探究雄性激素受体(AR)及Ki-67表达水平与三阴性乳腺癌超声特征的关系。方法:回顾性选取2021年5月—2023年4月在抚州市第一人民医院进行治疗的三阴性乳腺癌患者92例。所有患者均行超声检查,并采用免疫组化二步法检测Ki-67及AR的表... 目的:探究雄性激素受体(AR)及Ki-67表达水平与三阴性乳腺癌超声特征的关系。方法:回顾性选取2021年5月—2023年4月在抚州市第一人民医院进行治疗的三阴性乳腺癌患者92例。所有患者均行超声检查,并采用免疫组化二步法检测Ki-67及AR的表达情况。比较Ki-67、AR阳性表达三阴性乳腺癌患者的临床参数、AR阳性表达及不同表达水平Ki-67三阴性乳腺癌患者的超声特征。结果:Ki-67及AR在三阴性乳腺癌中的阳性表达率分别为90.22%(83/92)、35.87%(33/92);Ki-67阳性患者的Ⅲ、Ⅳ期比例高于阴性患者,AR阳性患者Ⅰ、Ⅱ期比例高于阴性患者,差异均有统计学意义(P<0.05);不同Ki-67、AR表达患者的年龄、肿瘤部位、肿瘤最大直径比较,差异均无统计学意义(P>0.05);AR阳性患者边缘毛刺无成角和血流信号0、1级比例均高于阴性患者,差异均有统计学意义(P<0.05);Ki-67高表达组边缘毛刺成角、形态不规则、钙化、后方回声衰减、内部回声非低回声及血流信号2、3级比例均高于低表达组(P<0.05)。结论:AR阳性表达的三阴性乳腺癌患者,边缘毛刺无成角及血流信号0、1级的比例高,Ki-67高表达的三阴性乳腺癌患者,边缘毛刺成角、形态不规则、钙化、后方回声衰减、内部回声非低回声及血流信号2、3级比例高。 展开更多
关键词 雄性激素受体 KI-67 三阴性乳腺癌 超声特征
下载PDF
Androgen signaling inhibits de novo lipogenesis to alleviate lipid deposition in zebrafish
12
作者 Jing-Yi Jia Guang-Hui Chen +6 位作者 Ting-Ting Shu Qi-Yong Lou Xia Jin Jiang-Yan He Wu-Han Xiao Gang Zhai Zhan Yin 《Zoological Research》 SCIE CSCD 2024年第2期355-366,共12页
Testosterone is closely associated with lipid metabolism and known to affect body fat composition and muscle mass in males.However,the mechanisms by which testosterone acts on lipid metabolism are not yet fully unders... Testosterone is closely associated with lipid metabolism and known to affect body fat composition and muscle mass in males.However,the mechanisms by which testosterone acts on lipid metabolism are not yet fully understood,especially in teleosts.In this study,cyp17a1-/-zebrafish(Danio rerio)exhibited excessive visceral adipose tissue(VAT),lipid content,and up-regulated expression and activity of hepatic de novo lipogenesis(DNL)enzymes.The assay for transposase accessible chromatinwithsequencing(ATAC-seq)results demonstrated that chromatin accessibility of DNL genes was increased in cyp17a1-/-fish compared to cyp17a1+/+male fish,including stearoyl-CoA desaturase(scd)and fatty acid synthase(fasn).Androgen response element(ARE)motifs in the androgen signaling pathway were significantly enriched in cyp17a1+/+male fish but not in cyp17a1-/-fish.Both androgen receptor(ar)-/-and wildtype(WT)zebrafish administered with Ar antagonist flutamide displayed excessive visceral adipose tissue,lipid content,and up-regulated expression and activity of hepatic de novo lipogenesis enzymes.The Ar agonist BMS-564929 reduced the content of VAT and lipid content,and down-regulated acetyl-CoA carboxylase a(acaca),fasn,and scd expression.Mechanistically,the rescue effect of testosterone on cyp17a1-/-fish in terms of phenotypes was abolished when ar was additionally depleted.Collectively,these findings reveal that testosterone inhibits lipid deposition by down-regulating DNL genes via Ar in zebrafish,thus expanding our understanding of the relationship between testosterone and lipid metabolism in teleosts. 展开更多
关键词 Cyp17a1 TESTOSTERONE androgen receptor De novo lipogenesis Fatty acid synthesis
下载PDF
Androgen Receptor Promotes Lung Cancer Metastasis by Modifying the miR23a-3p/EPHB2 Pathway
13
作者 Yan YANG Jing-wen HUANG Wei-wei YU 《Current Medical Science》 SCIE CAS 2024年第5期954-963,共10页
Objective This study aimed to investigate the reasons behind the lower survival rates in male lung cancer patients than in female lung cancer patients.Methods Through various techniques,such as Argonaute immunoprecipi... Objective This study aimed to investigate the reasons behind the lower survival rates in male lung cancer patients than in female lung cancer patients.Methods Through various techniques,such as Argonaute immunoprecipitation,luciferase assays,and ChIP,this study confirmed the positive effects of androgen receptor(AR)on lung cancer cell invasion across different in vitro cell lines and in vivo mouse models.Results The findings suggest that AR enhanced the invasion of lung cancer cells by modifying EPHB2 signals at the protein expression level,which in turn required changes in miRNA-23a-3p.Restoring miRNA-23a-3p could counteract the intensified invasion of lung cancer cells mediated by AR.Conclusion This study revealed that AR may facilitate the lung cancer matastasis by modulating miRNA-23a-3p/EPHB2 signaling and that targeting this signaling pathway could provide new approaches to inhibit lung cancer metastasis. 展开更多
关键词 androgen receptor lung cancer metastasis miRNA-23a-3p EPHB2
下载PDF
N-acetylcysteine and zinc sulphate abate di-2-ethylhexyl phthalate-mediated reproductive dysfunction in rats:Focus on oxidative and sex hormone receptors mechanisms
14
作者 Victor Oghenekparobo Emojevwe Mega Obukohwo Oyovwi +7 位作者 Kayode Ezekiel Adewole Peggy Ejiro Ohwin Adeniran Oluwadamilare Akinola Alexander Obidike Naiho Eze Kingsley Nwangwa Victor Omo-Idonije Motunrayo Lade-Ige Benneth Ben-Azu 《Asian pacific Journal of Reproduction》 CAS 2024年第5期228-240,共13页
Objective:To investigate the potential of N-acetylcysteine(NAC)and zinc sulphate(ZnSO_(4))in mitigating reproductive dysfunction caused by di-2-ethylhexyl phthalate(DEHP)in rats and to understand the underlying mechan... Objective:To investigate the potential of N-acetylcysteine(NAC)and zinc sulphate(ZnSO_(4))in mitigating reproductive dysfunction caused by di-2-ethylhexyl phthalate(DEHP)in rats and to understand the underlying mechanisms,specifically oxidative stress and sex hormone receptor activity.Methods:Thirty-five male Wistar rats were randomly divided into five equal groups(n=7 per group).Group 1 was administered 0.5 mL of distilled water and served as the control group.Group 2 was given only DEHP(750 mg/kg/day),while group 3,4 and 5 were given DEHP(750 mg/kg/day)plus NAC(100 mg/kg/day),DEHP(750 mg/kg/day)plus ZnSO_(4)(0.5 mg/kg/day),and DEHP(750 mg/kg/day)plus NAC(100 mg/kg/day)as well as ZnSO_(4)(0.5 mg/kg/day),respectively.All treatments lasted for 21 days.Samples were obtained after the rats were sacrificed,and hormones levels in the serum and markers of oxidative stress in the testicles were analyzed using the enzyme-linked immunosorbent assay.The amount of androgen receptors in the testicles was determined by immunohistochemistry,and the susceptibility of testosterone and DEHP to bind to androgen receptor and 5α-reductase was determined by molecular docking studies.Results:DEHP decreased reproductive hormones,testicular antioxidant enzymes,increased malondialdehyde levels,and negatively impacted histology of the pituitary and testes.NAC or ZnSO_(4) treatment showed a marked improvement in testicular antioxidant status and hormone levels,as well as a positive effect on the histology of the pituitary and testes.The combination of both treatments appeared to be more effective.The affinity of DEHP to bind to androgen receptors may lead to disruption of androgen receptor signaling,which can further result in dysfunction of hormones related to androgen.However,NAC is more likely to form stronger binding interactions with follicle stimulating hormone and luteinizing hormone receptors,as well as gonadotropin-releasing hormone receptors,when compared to DEHP.Conclusions:The possibility that NAC and ZnSO_(4) could downregulate DEHP-induced sex hormone changes is suggested by their potential to reduce toxicity. 展开更多
关键词 Di-2-ethylhexyl phthalate TESTOSTERONE androgen receptor 5Α-REDUCTASE OESTROGEN Luteinizing hormone
下载PDF
基于β1-AR/TGF-β1/Smad2通路探讨稳心颗粒对异丙肾上腺素诱导的大鼠心肌纤维化的影响
15
作者 于露 邓芳隽 +3 位作者 梁嘉钰 樊博雅 钱舒乐 李晓凤 《环球中医药》 CAS 2024年第8期1507-1514,共8页
目的探讨稳心颗粒通过β1-AR/TGF-β1/Smad2通路对异丙肾上腺素(isoproterenol,ISO)诱导大鼠心肌纤维化的影响。方法雄性SD大鼠60只,随机分为对照组、ISO组与稳心颗粒低、中、高剂量组以及胺碘酮组,每组10只,连续给药14天。第15天起,IS... 目的探讨稳心颗粒通过β1-AR/TGF-β1/Smad2通路对异丙肾上腺素(isoproterenol,ISO)诱导大鼠心肌纤维化的影响。方法雄性SD大鼠60只,随机分为对照组、ISO组与稳心颗粒低、中、高剂量组以及胺碘酮组,每组10只,连续给药14天。第15天起,ISO组、各药物组大鼠以ISO 5 mg/(kg•d)皮下多点注射构建大鼠心肌纤维化模型。检测大鼠心脏质量指数的变化;采用苏木素—伊红(hematoxylin-eosin,HE)染色观察心肌形态学变化,Masson染色观察心肌胶原分布和含量变化;检测心肌组织羟脯氨酸(hydroxyproline,HYP)和谷胱甘肽过氧化物酶(glutathione peroxidase,GSH-PX)的含量;蛋白免疫印迹法(Western blot,WB)检测大鼠心肌组织交感神经系统-β1肾上腺素能受体(β1 adrenoceptor,β1-AR)、转化生长因子β1(transforming growth factor-β,TGF-β1)、p-Smad2蛋白表达变化。结果ISO组大鼠心脏质量指数明显升,细胞结构紊乱,胶原沉积和心肌纤维化明显,心肌HYP含量显著增多,GSH含量减少,β1-AR、TGF-β1与p-Smad2表达水平显著升高(P<0.01);与ISO组相比,各治疗组心脏质量指数降低,细胞结构损伤与胶原沉积减轻,心肌纤维化改善,HYP含量降低,GSH含量增多,β1-AR、TGF-β1与p-Smad2表达水平明显降低(P<0.05,P<0.01)。稳心颗粒高剂量组效果较稳心颗粒低剂量组更为明显(P<0.05),与胺碘酮组相比无明显差异(P>0.05)。结论稳心颗粒能够改善ISO引起的心肌纤维化,减轻心肌细胞损伤与胶原纤维堆积,其机制可能与β1-AR/TGF-β1/Smad2通路有关。 展开更多
关键词 稳心颗粒 异丙肾上腺素 心肌纤维化 交感神经系统-β1肾上腺素能受体 转化生长因子β1 SMAD2
下载PDF
miR-141-3p Suppresses Expression of Androgen Receptors and Functions as a Tumor Suppressor Gene in Prostate Carcinogenesis
16
作者 Chunjiao Song Huan Chen +3 位作者 Tingzhang Wang Guomei Ru Qiannan Ding Wanlei Yang 《International Journal of Clinical Medicine》 2017年第2期55-72,共18页
Background: Prostate cancer (PCa) is a leading cause of tumor mortality in Western societies. In China, the PCa mortality rate is increasing yearly. Androgen receptors (ARs) and microRNAs (miRNAs) play central roles i... Background: Prostate cancer (PCa) is a leading cause of tumor mortality in Western societies. In China, the PCa mortality rate is increasing yearly. Androgen receptors (ARs) and microRNAs (miRNAs) play central roles in prostate carcinogenesis and progression. Methods: To characterize the underlying molecular mechanisms, we compared the miRNA profiles of early PCa (G ≤ 7), advanced PCa (G > 7) and non-tumor prostate tissues using deep-sequencing. The target genes of differentially expressed miRNAs were predicted by bioinformatics analysis and confirmed by luciferase reporter assays and Western blot (WB) and quantitative reverse transcription-PCR (qRT-PCR) analyses. Finally, we performed in vitro functional studies by inducing or inhibiting miR-141-3p expression using an artificial mimic or inhibitor. Results: A computational search implicated the open reading frame (ORF) of AR mRNA as a potential miR-141-3p target site. The qRT-PCR, WB and luciferase reporter assays revealed a reverse regulatory effect of miR-141-3p on AR. Mutation of the potential miR-141-3p binding site in the AR ORF resulted in a loss of responsiveness to the corresponding miRNA. Moreover, miR-141-3p expression levels were unchanged in early PCas, but were obviously increased in advanced PCas. MiR-141-3p overexpression inhibited RWPE-1 cell proliferation, mobility, and prohibited the entry of cells into the G2-S-M phase;miR-141-3p inhibition had the inverse effects. At the same time, we tested miR-141-3p’s functions in PC-3 and VCaP prostate cancer cell lines. Conclusions: Taken together, our results indicate that miR-141-3p targets AR and its downstream signaling pathways, and functions as a tumor suppressor miR in PCa carcinogenesis by suppressing cell growth and mobility, but the effect is not significant in maglinant PCas. MiR-141-3p is implicated as a novel therapeutic target for early PCa. 展开更多
关键词 PROSTATE Cancer miR-141-3p androgen RECEPTOR CarCINOGENESIS
下载PDF
AR在ER阳性和阴性乳腺癌中的表达及其临床意义 被引量:1
17
作者 陶豫洁 张琳 陈东辉 《实用癌症杂志》 2023年第6期879-881,887,共4页
目的分析雄激素受体(AR)在雌激素受体(ER)阳性与阴性乳腺癌患者中的表达及其临床意义。方法回顾性分析120例乳腺癌患者的病历资料,按ER的阴性、阳性的不同将其分为两组。其中75例ER阳性患者纳入观察组,45例ER阴性患者纳入对照组,统计对... 目的分析雄激素受体(AR)在雌激素受体(ER)阳性与阴性乳腺癌患者中的表达及其临床意义。方法回顾性分析120例乳腺癌患者的病历资料,按ER的阴性、阳性的不同将其分为两组。其中75例ER阳性患者纳入观察组,45例ER阴性患者纳入对照组,统计对比AR在ER阳性、ER阴性患者中的表达差异;并分析AR表达与ER阳性、ER阴性患者的临床病理特征的关系;另分析AR表达与乳腺癌患者预后的关系。结果观察组AR阳性表达率[85.33%(64/75)]高于对照组[66.67%(30/45)],差异有统计学意义(P<0.05);在观察组中,AR表达与肿瘤组织学分级有关(P<0.05);在对照组中,AR表达与肿瘤组织学分级、神经侵犯、脉管侵犯、淋巴结转移、临床分期有关(P<0.05);观察组AR阳性表达患者的生存率[90.63%(58/64)]高于AR阴性表达患者[54.55%(6/11)],而对照组AR阳性表达患者的生存率[40.00%(12/30)]低于AR阴性表达者[73.33%(11/15)],差异有统计学意义(P<0.05)。结论AR阳性率在ER阳性与阴性乳腺癌患者间存在显著差异,且与患者临床病理特征的关系亦存在明显不同,与ER阴性的AR阳性表达乳腺癌患者相比,ER阳性表达的AR阳性表达患者具有更优良的预后。 展开更多
关键词 乳腺癌 雌激素受体 雄激素受体 预后 淋巴结转移
下载PDF
Androgen receptor signaling in hepatocellular carcinoma and pancreatic cancers 被引量:10
18
作者 Tatsuo Kanda Xia Jiang Osamu Yokosuka 《World Journal of Gastroenterology》 SCIE CAS 2014年第28期9229-9236,共8页
Hepatocellular carcinoma (HCC) and pancreatic cancer remain difficult to treat, and despite the ongoing development of new treatments, the overall survival rate has only modestly improved over the past decade. Liver a... Hepatocellular carcinoma (HCC) and pancreatic cancer remain difficult to treat, and despite the ongoing development of new treatments, the overall survival rate has only modestly improved over the past decade. Liver and pancreatic progenitors commonly develop from endoderm cells in the embryonic foregut. A previous study showed that HCC and pancreatic cancer cell lines variably express androgen receptor (AR), and these cancers and the surrounding tissues also express AR. AR is a ligand-dependent transcription factor that belongs to the nuclear receptor superfamily. Androgen response element is present in regulatory elements on the AR-responsive target genes, such as transforming growth factor beta-1 (TGF beta-1) and vascular endothelial growth factor (VEGF). It is well known that the activation of AR is associated with human carcinogenesis in prostate cancer as well as HCC and pancreatic cancer and that GRP78, TGF beta, and VEGF all play important roles in carcinogenesis and cancer development in these cancers. HCC is a male-dominant cancer irrespective of its etiology. Previous work has reported that vertebrae forkhead box A 1/2 are involved in estrogen receptors and/or AR signaling pathways, which may contribute to the gender differences observed with HCC. Our recent work also showed that AR has a critical role in pancreatic cancer development, despite pancreatic cancer not being a male dominant cancer. Aryl hydrocarbon (or dioxin) receptor is also involved in both HCC and pancreatic cancer through the formation of complex with AR. It is possible that AR might be involved in their carcinogenesis through major histocompatibility complex class&#x02005;I&#x02005;chain-related gene A/B. This review article describes AR and its role in HCC and pancreatic cancer and suggests that more specific AR signaling-inhibitors may be useful in the treatment of these &#x0201c;difficult to treat&#x0201d; cancers. 展开更多
关键词 androgen receptor Gender difference Hepatocellular carcinoma Male-dominant PANCREAS
下载PDF
In situ hybridization assay of androgen receptor gene in hepatocarcinogenesis 被引量:7
19
作者 ZHAO Guo Qiang, XUE Ling, XU Hong Yu, TANG Xi Ming, HU Rui De and DONG Jun 《World Journal of Gastroenterology》 SCIE CAS CSCD 1998年第6期48-50,共3页
AIM To determine the correlation between expression of androgen receptor (AR) gene and hepatocarcinogenesis. METHODS Male SD rats were used as experimental animals and the animal model of experimental hepatocarcino... AIM To determine the correlation between expression of androgen receptor (AR) gene and hepatocarcinogenesis. METHODS Male SD rats were used as experimental animals and the animal model of experimental hepatocarcinoma was established by means of 3′ me DAB administration. Androgen receptor mRNA was detected by a non radioactive in situ hybridization assay in neoplastic and non neoplastic liver tissues. RESULTS The expression of androgen receptor mRNA was observed only in neoplastic cells and some atypical hyperplastic cells. In the liver tissue of control animal and the remaining normal liver cells adjacent to the carcinoma tissue, no positive signal was seen. CONCLUSION Androgen has an important correlation with hepatocarcinogenesis and the expression of androgen receptor gene might be a mark event during hepatocarcinogenesis. 展开更多
关键词 HEPATOCarCINOMA androgen RECEPTOR in SITU HYBRIDIZATION liver neoplasm experimental
下载PDF
Chimeric molecules facilitate the degradation of androgen receptors and repress the growth of LNCaP cells 被引量:7
20
作者 Yue-Qing Tang Bang-Min Han +6 位作者 Xin-Quan Yao Yan Hong Yan Wang Fu-Jun Zhao Sheng-Qiang Yu Xiao-Wen Sun Shu-Jie Xia 《Asian Journal of Andrology》 SCIE CAS CSCD 2009年第1期119-126,共8页
Post-translational degradation of protein plays an important role in cell life. We employed chimeric molecules (dihydrotestosterone-based proteolysis-targeting chimeric molecule [DHT-PROTAC]) to facilitate androgen ... Post-translational degradation of protein plays an important role in cell life. We employed chimeric molecules (dihydrotestosterone-based proteolysis-targeting chimeric molecule [DHT-PROTAC]) to facilitate androgen receptor (AR) degradation via the ubiquitin-proteasome pathway (UPP) and to investigate the role of AR in cell proliferation and viability in androgen-sensitive prostate cancer cells. Western blot analysis and immunohistochemistry were applied to analyse AR levels in LNCaP cells after DHT-PROTAC treatment. Cell counting and the 3-(4,5-dimethylthiazol-2-yl)-2,5- diphenyl tetrazolium bromide (MTT) cell viability assay were used to evaluate cell proliferation and viability after AR elimination in both LNCaP and PC-3 cells. AR was tagged for elimination via the UPP by DHT-PROTAC, and this could be blocked by proteasome inhibitors. Degradation of AR depended on DHT-PROTAC concentration, and either DHT or an ALAPYIP-(arg)8 peptide could compete with DHT-PROTAC. Inhibition of cell proliferation and decreased viability were observed in LNCaP cells, but not in PC-3 or 786-0 cells after DHT-PROTAC treatment. These data indicate that AR elimination is facilitated via the UPP by DHT-PROTAC, and that the growth of LNCaP cells is repressed after AR degradation. 展开更多
关键词 androgen receptor LNCAP prostate cancer PROTEOLYSIS UBIQUITIN
下载PDF
上一页 1 2 80 下一页 到第
使用帮助 返回顶部